Latest Regulatory Risk News

Dusk Group has carried its FY26 momentum into the new financial year, with like-for-like sales up 7.2% in the first 15 weeks despite operating six fewer stores. The home-fragrance retailer is now preparing a tightly controlled South African launch while an unresolved ACCC court case remains a material complication.

Adveritas has secured a $2 million placement at a 42.9% premium to its last close, with the proceeds earmarked for product development, marketing and working capital. The funding comes as the company pushes beyond sports betting and gaming while managing delayed Brazilian customer payments.

WiseTech Global’s FY26 annual report charts a year of extraordinary expansion, with revenue up 79% after the e2open acquisition and underlying EBITDA up 56%. But the stronger earnings base comes with heavier debt, a major workforce reset and unresolved regulatory risks.

AXP Energy has launched a 1-for-1 non-renounceable entitlement offer seeking between A$1.2 million and A$2.249 million. The funding could support Oklahoma development, but the prospectus also highlights material going-concern uncertainty, creditor dependence and significant dilution for shareholders who do not participate.

DPM Metals produced 97,000 gold equivalent ounces in the third quarter and now expects to reach the high end of its 2026 production guidance. Vareš is running ahead of expectations, but its growth plans remain exposed to an unresolved legal review in Bosnia and Herzegovina.

Aurum Resources has confirmed that the Boundiali assay information was market-sensitive, while defending the timing and validity of a cleansing notice issued before the results were released. ASX has not indicated whether it accepts the company’s explanation.

Sigma Lithium says a Federal Court of Appeals decision has restored the environmental licences supporting its Grota do Cirilo operation, allowing mining and processing to resume. The company has also reaffirmed its target of reaching 330,000 tonnes of annualised lithium oxide concentrate production by year-end 2027.

Vertex Minerals’ Reward Gold Mine produced 679 ounces in its first production year, but the transition came with a A$16.4 million loss, negative operating cash flow and a formal going-concern warning. The company now faces a narrow window to prove its mechanised mining plan can lift production before debt repayments and further funding decisions bite.

Port of Tauranga’s Stella Passage development has been hit by an appeal and a judicial review application from tangata whenua parties. The port says the project remains urgent and will seek the earliest possible court hearing, but has disclosed no estimate of the legal or financial impact.

Investor Centre’s FY2025 report lays bare the financial strain behind its proposed revival: revenue collapsed, cash fell to just $3,320 and liabilities exceeded assets by $3.81 million. The company is now relying on an unsecured Lake Volta Investments facility and a non-binding restructuring plan after its brokerage subsidiary lost its AFSL.

Clarity Pharmaceuticals is approaching pivotal Phase III readouts for its prostate cancer imaging agent, backed by AUD178.3 million in liquid assets. The radiopharmaceutical developer remains deeply loss-making, but expanded manufacturing capacity and early clinical signals are pulling its commercial ambitions into sharper focus.

Atlas Arteria has warned that France may more than double the tax rate applied to eligible toll-road operators, with APRR’s 2025 TEILD bill already reaching €126.7 million. The proposed changes remain subject to parliamentary debate and could be softened before becoming law.